How Contagious Is TB? Airborne Risk Explained

Tuberculosis is highly contagious in its active pulmonary form, with an infectious dose of fewer than 10 bacteria needed to establish a new infection. Among close contacts of someone with active TB, roughly 46% become infected. But the full picture is more nuanced: only people with active TB disease in the lungs or airway can spread it, and most people exposed never develop symptoms.

How TB Spreads Through the Air

TB spreads exclusively through the air. When someone with active pulmonary TB coughs, speaks, or sings, they release tiny particles called droplet nuclei that contain the bacteria. These particles are small enough to stay suspended in the air for hours and can be inhaled deep into the lungs by anyone sharing the same space.

This is not a surface-contact disease. You cannot catch TB from shaking hands, sharing utensils, or touching doorknobs. The bacteria need to reach the deepest parts of your lungs to take hold, which only airborne particles can accomplish. That said, the number of bacteria required is remarkably small. Fewer than 10 organisms can be enough to start an infection, making TB one of the more efficiently transmitted airborne diseases when conditions allow.

Who Can Actually Spread It

Only people with active TB disease in their lungs, airways, or voice box (larynx) are contagious. This is a critical distinction, because roughly a quarter of the world’s population carries latent TB, a dormant form of the infection that cannot be spread to others. In latent TB, the immune system walls off the bacteria inside tiny structures called granulomas, effectively trapping them and preventing them from reaching the airways.

TB that affects other parts of the body, such as bones, kidneys, or the brain, is generally not contagious either. The exceptions are rare: if someone also has lung involvement, if the infection is in the mouth or larynx, or if there’s an open wound draining heavily enough to create airborne particles.

Risk for Close Contacts

A meta-analysis of contact studies found that about 46% of close contacts of someone with active, smear-positive pulmonary TB test positive for infection. Of those close contacts, roughly 2.7% develop active TB disease themselves. “Close contact” typically means people sharing a household, though it can include coworkers or others who spend extended time in the same enclosed space.

Several factors influence your actual risk during any given exposure:

  • Duration and proximity. Brief, passing contact carries far less risk than sleeping in the same room for weeks.
  • Ventilation. Well-ventilated spaces dilute airborne bacteria quickly. Mechanical ventilation systems that cycle air at least six times per hour significantly reduce the concentration of infectious particles. Ultraviolet light systems in clinical settings can add the equivalent of 10 to 39 additional air changes per hour by killing airborne bacteria.
  • Bacterial load. People who are coughing frequently and have high bacterial counts in their sputum are far more contagious than those with lower counts.
  • Humidity and sunlight. TB bacteria survive longer in humid, poorly lit environments. Keeping indoor humidity below 60% and temperatures between 20°C and 24°C reduces bacterial survival.

Latent TB and the Risk of Becoming Contagious

If you’ve been exposed and your immune system contains the bacteria, you have latent TB infection. You feel completely healthy, have no symptoms, and cannot pass TB to anyone else. But the bacteria aren’t gone. They’re dormant, and in about 5% of otherwise healthy adults, they reactivate into full-blown disease within the first two years. The remaining lifetime risk adds several more percentage points, particularly for people with weakened immune systems.

HIV, diabetes, malnutrition, immunosuppressive medications, and very young or old age all increase the likelihood of progression from latent to active disease. This is why public health programs prioritize treating latent TB in high-risk individuals: stopping the bacteria before they can reactivate eliminates both the personal health threat and any future contagiousness.

How Quickly Treatment Stops the Spread

Once someone with drug-susceptible TB starts appropriate antibiotic treatment, they are generally considered non-infectious after two weeks. During that initial period, patients are typically advised to stay home or remain in isolation if hospitalized. Clinical confirmation involves collecting sputum samples until three consecutive tests come back negative for the bacteria.

Drug-resistant TB is a different situation. When the bacteria don’t respond to standard antibiotics, the period before a patient becomes non-infectious can stretch considerably longer, and isolation precautions last accordingly. Health departments make the final call on when someone is safe to return to work, school, or air travel based on chest imaging, sputum test results, symptoms, and treatment response.

TB Compared to Other Airborne Diseases

TB occupies an unusual middle ground among infectious diseases. It is less immediately contagious than measles or chickenpox, which can infect nearly everyone in a room during a single exposure. A single TB exposure in a well-ventilated space might carry minimal risk. But TB compensates with persistence: the bacteria can linger in the air for hours, and prolonged, repeated exposure in enclosed spaces drives the high infection rates seen in households. The extremely low infectious dose, fewer than 10 bacteria, means that even modest exposures carry some risk if ventilation is poor.

Commercial air travel illustrates how public health authorities manage this risk. People with contagious TB are prohibited from flying on commercial aircraft, because the recirculated cabin air and prolonged close seating create exactly the conditions that favor transmission.